title: The Banff 2007 working classification of skin-containing composite tissue allograft pathology.
abstract: Composite tissue allotransplantation (CTA) is a recently introduced option for limb replacement and reconstruction of tissue defects. As with other allografts, CTA can undergo immune-mediated rejection; therefore standardized criteria are required for characterizing and reporting severity and types of rejection. This article documents the conclusions of a symposium on CTA rejection held at the Ninth Banff Conference on Allograft Pathology in La-Coruna, Spain, on 26 June 2007, and proposes a working classification, the Banff CTA-07, for the categorization of CTA rejection. This classification was derived from a consensus discussion session attended by the first authors of three published classification systems, pathologists and researchers from international centers where clinical CTA has been performed. It was open to all attendees to the Banff conference. To the extent possible, the format followed the established National Institutes of Health (NIH) guidelines on Consensus Development Programs. By consensus, the defining features to diagnose acute skin rejection include inflammatory cell infiltration with involvement of epidermis and/or adnexal structures, epithelial apoptosis, dyskeratosis and necrosis. Five grades of severity of rejection are defined. This classification refines proposed schemas, represents international consensus on this topic, and establishes a working collective classification system for CTA reporting of rejection in skin-containing CTAs.
authors.affiliation: Emory Transplant Center, Emory University, Atlanta, GA, USA. lcendal@emory.edu
authors.forename: L C
authors.initials: LC
authors.lastname: Cendales
authors.forename: J
authors.initials: J
authors.lastname: Kanitakis
authors.forename: S
authors.initials: S
authors.lastname: Schneeberger
authors.forename: C
authors.initials: C
authors.lastname: Burns
authors.forename: P
authors.initials: P
authors.lastname: Ruiz
authors.forename: L
authors.initials: L
authors.lastname: Landin
authors.forename: M
authors.initials: M
authors.lastname: Remmelink
authors.forename: C W
authors.initials: CW
authors.lastname: Hewitt
authors.forename: T
authors.initials: T
authors.lastname: Landgren
authors.forename: B
authors.initials: B
authors.lastname: Lyons
authors.forename: C B
authors.initials: CB
authors.lastname: Drachenberg
authors.forename: K
authors.initials: K
authors.lastname: Solez
authors.forename: A D
authors.initials: AD
authors.lastname: Kirk
authors.forename: D E
authors.initials: DE
authors.lastname: Kleiner
authors.forename: L
authors.initials: L
authors.lastname: Racusen
mesh_terms: D005121:Extremities / Q000473:pathology* / Q000637:transplantation*; D006084:Graft Rejection / Q000145:classification*; D006801:Humans; D012867:Skin / Q000276:immunology / Q000473:pathology*; D016038:Skin Transplantation / Q000276:immunology / Q000473:pathology*; D014184:Transplantation, Homologous